In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 315 for your search:
Drug:  cetuximab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DERMATUX, NCT01315990

2.

Phase: Phase III, Phase II
Type: Health services research, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000558804, WCTU-SCOPE-1, EU-20739, EUDRACT-2006-002241-37, ISRCTN47718479, CTA-17853/0202/001-0001, NCT00509561

3.

Phase: Phase III, Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UKM-MRC-FOCUS3-CR12, FOCUS 3 - CR12, EUDRACT-2008-008323-15, ISRCTN83171665, EU-20960, NCT00975897

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066954, ECOG-E5397, E5397, NCT00003809

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000350016, U10CA031946, CALGB-80203, NCT00077233

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA225-006, NCT00063141

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA225-014, NCT00061815

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor: NCI
Protocol IDs: NCI-2009-00639, N0147, U10CA025224, CDR0000355132, NCCTG-N0147, ECOG-N0147, NCT00079274

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13423, I4E-MC-JXBC, CP02-0452, NCT00095199

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA225-099, NCT00112294

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UKM-MRC-COIN-CR10, EU-20516, NCT00182715, EUDRACT-2004-002951-16, ISRCTN27286448, COIN

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 62202-002, NCT00122460

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 74
Sponsor: Other
Protocol IDs: Nordic VII, EudraCT no.: 2005-000117-34, NCT00145314

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 62202-046, NCT00148798

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAIRO2, NCT00208546

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 62202-013, NCT00154102

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 74
Sponsor: Other
Protocol IDs: CDR0000453839, FFCD-PETACC-8, EU-20547, EUDRACT-2005-003463-23, PETACC-8, MERCK-FFCD-PETACC-8, NCT00265811

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000455161, CALGB-C80405, SWOG-C80405, C80405, NCT00265850

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-041, NCT00252564

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0522, CDR0000458049, NCI-2009-00729, NCT00265941

21.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000492254, NCCTG-N05C4, N05C4, NCT00362986

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: FIRE-3, NCT00433927

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor: NCI, Other
Protocol IDs: RTOG 0436, CDR0000538085, NCT00655876

24.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0617, CDR0000564240, NCCTG-N0628, CALGB-30609, NCT00533949

25.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CO20, CAN-NCIC-CO20, CAN-NCIC-CA182009, CDR0000590316, NCT00640471
1     
New Search